Cary Street Partners Investment Advisory’s LumiraDx Limited Common Shares LMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-410
Closed -$197 1933
2023
Q2
$197 Hold
410
﹤0.01% 1715
2023
Q1
$191 Hold
410
﹤0.01% 1643
2022
Q4
$369 Buy
+410
New +$432 ﹤0.01% 1635

Other funds holding LMDX

Cary Street Partners Investment Advisory's LMDX Position: Q3 2023 in Review

Cary Street Partners Investment Advisory sold out of LumiraDx Limited Common Shares (LMDX) in Q3 2023, closing a stake of 410 shares — an estimated $197 sold.

Cary Street Partners Investment Advisory first reported a position in LMDX in Q4 2022 and held it in 3 quarters. The position peaked at $369 in Q4 2022. 34 funds tracked by Wall St. Rank hold LMDX as of Q3 2023.

  • Cary Street Partners Investment Advisory reported no remaining LumiraDx Limited Common Shares position as of Q3 2023 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 410 LumiraDx Limited Common Shares shares in Q3 2023, an estimated $197.
  • Cary Street Partners Investment Advisory first reported a position in LumiraDx Limited Common Shares in Q4 2022 and held it in 3 quarters.
  • Cary Street Partners Investment Advisory's LumiraDx Limited Common Shares position peaked at $369 in Q4 2022.
  • 34 funds tracked by Wall St. Rank held LumiraDx Limited Common Shares as of Q3 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q3 2023, filed 13 Nov 2023.